UnitedHealth Group

Oct 25, 2024

UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Lecap Asset Management Ltd. Posted by MarketBeat News on Oct 25th, 2024 Lecap Asset Management Ltd. decreased its stake in UnitedHealth Group Incorporated ( NYSE:UNH – Free Report ) by 66.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,011 shares of the healthcare conglomerate’s stock after selling 2,014 shares during the quarter. Lecap Asset Management Ltd.’s holdings in UnitedHealth Group were worth $591,000 as of its most recent SEC filing. Several other large investors also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $27,000. Macroview Investment Management LLC increased its holdings in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC lifted its stake in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $31,000. Finally, Global Wealth Strategies & Associates grew its stake in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors. Get UnitedHealth Group alerts: UnitedHealth Group Trading Down 0.7 % Shares of UNH opened at $560.82 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The stock has a market cap of $517.87 billion, a price-to-earnings ratio of 36.56, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The firm has a 50 day simple moving average of $584.16 and a 200-day simple moving average of $536.49. Want More Great Investing Ideas? UnitedHealth Group ( NYSE:UNH – Get Free Report ) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the firm posted $6.56 earnings per share. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year. UnitedHealth Group Announces Dividend The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 54.72%. Analyst Ratings Changes A number of equities analysts have recently commented on UNH shares. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Wells Fargo & Company boosted their price target on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $615.53.